Serum withdrawal-induced apoptosis in thyroid cells is caused by loss of fibronectin-integrin interaction

T Di Matola1, F Mueller, G Fenzi

  • 1Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università Federico II, Naples, Italy.

Insights

Serum withdrawal induces anoikis, a form of apoptosis, in human thyroid cells by degrading fibronectin and disrupting cell-matrix adhesion. Adding fibronectin prevents this programmed cell death.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Anoikis, a form of apoptosis, is triggered by the loss of cell adhesion to the extracellular matrix in certain cell types.
  • Serum withdrawal can induce programmed cell death in various thyroid cell lines.
  • The role of the extracellular matrix in serum withdrawal-induced apoptosis in normal human thyroid cells requires investigation.

Purpose of the Study:

  • To determine the role of the extracellular matrix in serum withdrawal-induced apoptosis in normal human thyroid cells in primary culture.
  • To investigate the mechanism by which serum withdrawal affects cell-matrix adhesion and subsequent apoptosis.

Main Methods:

  • Primary human thyroid cells were cultured under serum-stimulated and serum-deprived conditions.
  • Production and deposition of insoluble fibronectin (FN) were assessed.
  • Cell adhesion was evaluated based on integrin-FN interactions.
  • Apoptosis was quantified using DNA fragmentation and annexin V staining.
  • The effect of exogenous immobilized FN on apoptosis was examined.

Main Results:

  • Serum stimulation induced selective production and deposition of insoluble fibronectin (FN) by thyroid cells.
  • Cell adhesion in the presence of serum relied on integrin-FN interactions.
  • Serum withdrawal led to degradation of deposited FN and cell detachment.
  • Cells undergoing detachment and FN degradation exhibited anoikis, confirmed by DNA fragmentation and annexin V staining.
  • Supplementation with exogenous immobilized FN prevented serum withdrawal-induced apoptosis.

Conclusions:

  • Serum withdrawal triggers apoptosis in normal human thyroid cells.
  • This apoptosis is mediated by the degradation of fibronectin and subsequent loss of cell-matrix adhesion.
  • Fibronectin plays a crucial role in maintaining thyroid cell survival under serum-deprived conditions.

Related Concept Videos

Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...